Blue Spoon Consulting Updates Briefing Note: `Pharmaceutical Promotion At Its Productivity Frontier

Blue Spoon Consulting Group, LLC, today updated its briefing note examining the degrading trends in pharmaceutical marketing, and what can be done about it. Available for download through t`Pharmaceutical Promotion At Its Productivity Frontier` is currently the only piece of strategic writing that looks at a total context of change shaping how pharmaceutical companies market and measure performance. It is updated periodically to integrate significant industry events. Opportunity to create new platforms for growth is also explored.

Blue Spoon is a leading strategy and marketing innovation consultancy serving the global pharmaceutical, health products, and information technology industries. Blue Spoon was the first to publish a new commercial model for drug marketing1, the first to design a new architecture for grand strategy in the pharmaceutical industry, and has pioneered a framework to improve business performance at a system level, an approach that enables an evolutionary leap in solutions for growth and competitive advantage.

Blue Spoon Consulting Publishes White Paper: Pharmaceutical Industry Strategy for a Global Economic System

NEW YORK, NY – Blue Spoon Consulting Group, LLC, today published a white paper that provides context for the pharmaceutical industry to reorient itself strategically. As momentum grows for performance-based contracting and bulk buying pools, drug companies will need new kinds of strategic ideas that simultaneously create markets and improve health outcomes. Available for download through the Blue Spoon Consulting website www.bluespoonconsulting.com, this white paper helps develop perspective and approach.

Blue Spoon is a strategy and marketing consultancy for the pharmaceutical industry. We are at the leading edge with a framework to help clients innovate their tactics, differentiate their strategies, and create at a system level. Simply put, Blue Spoon is different. We deliver an evolutionary leap in solutions for growth and competitive advantage. 

Pharmaceutical Promotion At Its Productivity Frontier

NEW YORK, NY Blue Spoon Consulting Group, LLC, today published a briefing note that looks at the simultaneous interplay of business dynamics shaping the pharmaceutical, marketing services, and data vendor industries.  Available for download through the Blue Spoon Consulting website (www.bluespoonconsulting.com), this is among the first pieces of strategic writing with a field of vision this broad.  Opportunity for market innovation is also explored, including creating new health ecosystems in respiratory and cardiovascular disease, as well as diabetes.

 

Blue Spoon is a strategy and marketing consultancy for the pharmaceutical industry.  We are at the leading edge with a framework to help clients innovate their tactics, differentiate their strategies, and create at a system level.  Simply put, Blue Spoon is different.  We deliver an evolutionary leap in solutions for growth and competitive advantage.

Pharmaceutical Industry Strategy for Integrated Delivery Networks

Pharmaceutical Industry Strategy for Integrated Delivery Networks Blue Spoon Publishes Approach to Regionalization, Value Innovation

NEW YORK, - Blue Spoon Consulting Group, LLC, today published a strategy for pharmaceutical companies to create a new value proposition for integrated delivery networks, and to work collaboratively with IDNs on improving health outcomes in the United States. Available as a white paper for download through the Blue Spoon Consulting website, the approach re-assembles the building blocks to health within a new industry ecosystem, producing a new market solution for a range of players simultaneously.

Disconnected government policy, lack of continuity of care, poor information exchange, and fragmented service systems are persistent problems in the provision of health for nearly every industrialized country in the world. The strategic challenge for reform, policy entrepreneurship, and industry and government leadership is transcending the current environment to achieve structural change. This unmet need for market organization and systemic collaboration is where pharmaceutical companies have an opportunity to re-shape the dynamics that influence their business.

Prospects for market power and premium pricing - objectives for commercial model innovation, something most pharmaceutical companies are struggling with - will come from leading the design of new industry architectures around shared marketspace. Using diabetes to illustrate the approach, players in the drug, nutrition, infrastructure technology, and content aggregation industries are linked as keystones in a new health ecosystem. The ecosystem can be positioned as a clean slate 'bolt on' to existing health systems, or as a service innovation that providers and integrated delivery networks can use for competitive strategy. The white paper also addresses a new role for government policy, suggesting a shift from administrator to "mediator" between system components can enable structural transformation.

Blue Spoon is a strategy and marketing consultancy for the pharmaceutical industry. We are at the leading edge with a framework to help clients innovate their tactics, differentiate their strategies, and create at a system level. Simply put, Blue Spoon is different. We deliver an evolutionary leap in solutions for growth and competitive advantage.